跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33,557 条关于
“D. Boral Capital LLC”
全部
33,557
临床试验
19,570
药物
2,478
机构
4,793
资讯
6,716
去年
Apimeds Pharmaceuticals Raises $13.5 Million in IPO for Bee Venom-Based Therapy Development
11个月前
Humacyte Secures $60 Million in Oversubscribed Offering to Advance Bioengineered Tissue Platform
去年
Omeros Raises $22 Million in Direct Offering to Fund Narsoplimab Development Amid Regulatory Review
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
10个月前
GHO Capital Partners Acquires AI-Powered R&D Platform Scientist.com to Accelerate Pharmaceutical Research Efficiency
9个月前
OTR Therapeutics Secures $100 Million Series A to Build Capital-Efficient R&D Platform in Shanghai
上个月
R&D Portfolio Prioritization Emerges as Critical Lever as Pharma Faces Patent Cliff and Capital Constraints
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
7个月前
Quince Therapeutics Engages LifeSci Capital for Strategic Review as Stock Surges Over 300%
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
第 1 页,共 672 页
上一页
下一页